Cho’s study revealed that RGS2 enhances dormancy cancer cells’ anti-apoptotic ability induced by endoplasmic reticulum stress through modulation of ATF4 expression, correlating with tumor recurrence and chemotherapy resistance27. This evidence concerns the gene RGS2 and neoplasm.